Evolent Health, Inc. (NYSE:EVH) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $44.00 to $41.00. They now have a "buy" rating on the stock.
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at JMP Securities from $38.00 to $34.00. They now have a "market outperform" rating on the stock.
Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
Evolent Health (EVH) Q1 2024 Earnings Call Transcript [Yahoo! Finance]